FDA to investigate Lilly's handling of Zyprexa data - FierceBiotech

FDA to investigate Lilly's handling of Zyprexa data - FierceBiotech: "The FDA has opened an inquiry to determine if Eli Lilly manipulated the data it submitted for Zyprexa, a controversial antipsychotic that has been linked to rapid weight gain and diabetes."